---
figid: PMC11790539__12672_2025_1815_Fig4_HTML
figtitle: Autophagy signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11790539
filename: 12672_2025_1815_Fig4_HTML.jpg
figlink: /pmc/articles/PMC11790539/figure/F4/
number: F4
caption: The autophagy signaling pathway. Astragalus alleviates thyroid cancer progression
  through the Sestrin2/AMPK/mTOR signaling pathway to promote autophagy and induce
  apoptosis. ATG3 and ATG5 promote autophagy and inhibit thyroid cancer cell proliferation
  via the RBM47/SNHG5/FOXO3 axis. Aloperine promotes caspase-dependent autophagy through
  the Akt signaling pathway and synergistically inhibits the PI3K/Akt/mTOR signaling
  pathway in combination with rapamycin to induce autophagy. BRAFV600E induces autophagy
  in the presence of the specific inhibitor PLX4720. Additionally, knockdown of BRAFV600E
  can modulate the LKB1/AMPK/mTOR signaling pathway, thereby inducing apoptosis
papertitle: 'Relationship between programmed cell death and targeted therapy for thyroid
  cancer in patients with a poor prognosis: an update'
reftext: Yuejia Zhao, et al. Discov Oncol. 2025 Dec;16(NA).
year: '2025'
doi: 10.1007/s12672-025-01815-w
journal_title: Discover Oncology
journal_nlm_ta: Discov Oncol
publisher_name: Springer
keywords: Programmed cell death | Thyroid cancer | Targeted therapy
automl_pathway: 0.947792
figid_alias: PMC11790539__F4
figtype: Figure
redirect_from: /figures/PMC11790539__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11790539__12672_2025_1815_Fig4_HTML.html
  '@type': Dataset
  description: The autophagy signaling pathway. Astragalus alleviates thyroid cancer
    progression through the Sestrin2/AMPK/mTOR signaling pathway to promote autophagy
    and induce apoptosis. ATG3 and ATG5 promote autophagy and inhibit thyroid cancer
    cell proliferation via the RBM47/SNHG5/FOXO3 axis. Aloperine promotes caspase-dependent
    autophagy through the Akt signaling pathway and synergistically inhibits the PI3K/Akt/mTOR
    signaling pathway in combination with rapamycin to induce autophagy. BRAFV600E
    induces autophagy in the presence of the specific inhibitor PLX4720. Additionally,
    knockdown of BRAFV600E can modulate the LKB1/AMPK/mTOR signaling pathway, thereby
    inducing apoptosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATG3
  - ATG5
  - BRAF
  - ATP8A2
  - APRT
  - MFAP1
  - RBM47
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MTOR
  - FOXO3
  - AKT1
  - AKT2
  - AKT3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - STK11
  - Aloperine
  - ATP
  - AMP
  - Rapamycin
  - PLX4720
  - cancer
  - Thyroid cancer
---
